Elsevier

Psychoneuroendocrinology

Volume 63, January 2016, Pages 296-310
Psychoneuroendocrinology

Review
The role of cytokines in the pathophysiology of suicidal behavior

https://doi.org/10.1016/j.psyneuen.2015.10.008Get rights and content

Highlights

  • We reviewed 22 articles concerning cytokines and suicidal ideation, suicide attempts or suicide completion.

  • The most consistent finding was elevated interleukin (IL)-6, found in 8 out of 14 studies, in CSF, blood, and postmortem brain, and associated with more violent attempts and future suicide completion.

  • Considerable heterogeneity among cytokine results indicates a high level of complexity.

  • Thus putative mediators and moderators of the effects of inflammation on suicide risk merit further study.

Abstract

Objective

Immune dysregulation has been implicated in depression and other psychiatric disorders. What is less clear is how immune dysregulation can affect risk of suicidal behavior. We reviewed the scientific literature concerning cytokines related to suicidal ideation, suicidal behavior and suicide, and surveyed clinical and neurobiological factors associated with cytokine levels that may modulate effects of inflammation on suicide risk.

Methods

We searched PubMed, Embase, Scopus and PsycINFO for relevant studies published from 1980 through February, 2015. Papers were included if they were written in English and focused on cytokine measurements in patients with suicidal behaviors.

Results

The literature search yielded 22 studies concerning cytokines and suicidal ideation, suicide attempts or suicide completion. The most consistent finding was elevated interleukin (IL)-6, found in 8 out of 14 studies, in CSF, blood, and postmortem brain. In one study, IL-6 in CSF was also found to be higher in violent than nonviolent attempters and to correlate with future suicide completion. Low plasma IL-2 was observed in 2 studies of suicide attempters, while divergent results were seen for tumor necrosis factor (TNF)-α, interferon (IFN)-γ, transforming growth factor (TGF)-β, IL-4, and soluble Il-2 receptors.

Conclusions

Given the complexity suggested by the heterogenous cytokine findings, putative mediators and moderators of inflammation on suicidal behavior merit further study. Elevated IL-6 was the most robust cytokine finding, associated with suicidal ideation and both nonfatal suicide attempts and suicides. Future studies should evaluate the predictive value of high IL-6, consider how this may alter brain function to impact suicidal behavior, and explore the potential beneficial effects of reducing IL-6 on suicide risk.

Introduction

Suicide is a major public health concern. The World Health Organization (WHO) estimated that in the year 2000, approximately one million people died from suicide, and 10–20 times more attempted suicide, worldwide (WHO, 2002). Suicide and suicidal behaviors are cross-diagnostic, multifactorial phenomena. Several clinical, psychosocial and demographic factors have been shown to increase the risk for suicidal behaviors (Hawton et al., 2013). However, predictive value of known risk factors for accurate assessment of who will ultimately make suicide attempts remains low (May et al., 2012). Therefore, identification of relevant biomarkers has assumed increasing importance in suicide research, as objective markers of risk could significantly improve the chances of effective clinical intervention. Moreover, greater understanding of the biological processes impacting neural pathways involved of suicide risk could suggest new treatment approaches.

Even though 90% of suicides have a psychiatric diagnosis (Beautrais et al., 1996), only 5% of psychiatric patients die by suicide. A Stress-Diathesis Model of suicidal behavior was proposed by Mann et al. (1999), in which suicidal behavior was conceptualized as the result of the interplay between stressors such as acute episodes of psychiatric illness or psychosocial stressors, and the individual's constitutional vulnerability to respond with suicidal behavior. This model thus implicates the stress-response system as a potential contributor to the pathophysiology of suicidal behavior. In humans, the hypothalamic-pituitary-adrenal (HPA) axis and the sympathetic nervous system play key roles in adaptation to physical or psychological stress, acting on numerous systems to maintain homeostasis through the release of corticosteroids and catecholamines (McEwen, 2008). However, chronic stress states in vulnerable individuals can produce alterations of basal and reactive cortisol which, in turn, can have deleterious effects on health. Maladaptive stress responses have been implicated in the pathophysiology of suicidal behavior (Oquendo et al., 2014). As the stress response is intrinsically linked with the immune system, the involvement of inflammatory responses must be considered in suicide-related pathophysiology.

Within the immune system, cytokines such as interleukins (IL), interferons (IFN), and tumor necrosis factor (TNF) play pivotal roles as signaling proteins mediating innate and adaptive immune responses (Commins et al., 2010). T-cell derived cytokines from the Th1 lineage are involved in cellular mediated immune processes (IL-1α, IL-1β, IL-2, IFN-γ, TNF-β) whereas those derived from the Th2 lineage promote humoral immune response (IL-4, IL-6, IL-10) and are implicated in allergic reactions (Chaplin, 2010). Certain cytokines can be functionally categorized as pro-inflammatory (IL-1, IL-6, TNF-α) or anti-inflammatory (IL-4, IL-10, IL-13) (Commins et al., 2010).

The role of cytokines in the pathophysiology of psychiatric disorders was postulated after observations that patients with inflammatory diseases had a higher prevalence of depression, and that symptoms similar to those observed in major depression could be provoked by administration of therapeutic cytokines, such as IFN-α (reviewed in (Raison et al., 2005)). Depression has been associated with increased inflammatory markers, including cytokines such as IL-6 and TNF-α (Liu et al., 2012), although inflammation may be implicated in only a subset of depressed patients (Raison and Miller, 2013).

In recent years, inflammation has emerged as potentially relevant in the pathophysiology of suicidal behavior. The earliest suggestions came from reports of suicidal ideation induced after medical treatment with therapeutic cytokines (Dieperink et al., 2004). A parallel set of discoveries stems from well-replicated findings that the incidence of suicide peaks during the spring, an initially baffling phenomenon later noted to covary with peak season for allergens (Postolache et al., 2008). Additional studies have directly linked allergic conditions to suicide completion (Qin et al., 2011, Timonen et al., 2004). Corroborative evidence is provided from an ecological study showing associations between intranasal corticosteroid anti-inflammatory therapy and lower suicide rates (Woo et al., 2011). In this review, we will focus on the contribution of later studies measuring inflammatory cytokines associated with suicidal behaviors in vivo or, in the case of completed suicide, on postmortem findings. We provide a critical overview of the literature and offer a contextualized interpretation of findings on how cytokine changes may alter brain function to favor suicidal behavior.

Identifying specific inflammatory markers and important contextual factors could inform suicide risk prediction. Treatments targeting constituents of the inflammatory pathway are currently undergoing testing for a variety of psychiatric conditions, and this approach could be developed as a novel therapeutic tool for the prevention of suicide.

Section snippets

Methods

Articles eligible for this review were identified by two investigators (L.G. and S.C.-T.) who independently performed database searches of PubMed from 1980 through February 2015, and Embase, Scopus and PsycINFO from 1980 until 2015 for articles in English (see Fig. 1). The final search strategy comprised the following (with slight differences for individual database logic rules): (suicid* AND (inflammat* OR cytokines OR chemokines OR “receptors, cytokines” OR “tumor necrosis factor” OR

Literature search

We found 22 articles that directly examined relationships between cytokines and suicidal ideation, suicidal behavior or suicide, that fulfilled the inclusion criteria, involving 1813 research participants. Ten articles concerned cytokines in suicide attempts (Huang and Lee, 2007, Isung et al., 2012a, Janelidze et al., 2011, Kim et al., 2008, Li et al., 2013, Lindqvist et al., 2011, Lindqvist et al., 2009, Nässberger and Träskman-Bendz, 1993, Rothenhäusler et al., 2006, Vargas et al., 2013),

Discussion

Taken together, the current literature suggests that inflammation plays a role in suicidal behavior, but the heterogeneity of specific findings, even among the two available meta-analyses, is considerable. Possible explanations for discrepancies among studies include the following: (1) different phenotypes of suicidal behavior may be associated with distinct biological inflammatory patterns, exemplified by findings of Karlović et al. (2012), in which IL-6 levels differed among suicidal compared

Conclusions

Suicide risk has been associated with chronic stress, HPA hyperactivity, serotonergic abnormalities, and in some studies, persistently elevated inflammatory markers, especially elevation of IL-6. Larger, methodologically rigorous studies are needed to draw definitive conclusions regarding the association of inflammatory proteins and suicide. Such studies would contribute to an integrated understanding of the interplay among these different elements, and allow the identification of proximate

Conflicts of interest

Drs. Mann and Oquendo receive royalties from the commercial use of the Columbia Suicide Severity Rating Scale (C-SSRS) from the Research Foundation for Mental Hygiene. Dr. Oquendo’s family owns stock in Bristol Myers Squibb. Drs. Gananca, Sublette, Cisneros-Trujillo and Tyrka have no conflicts to report.

Contributors

Drs. Gananca, Oquendo, Tyrka, Mann and Sublette participated in the conceptualization of the manuscript and interpretation of findings. Dr. Gananca wrote the first draft of the manuscript. Drs. Gananca and Cisneros-Trujillo performed the literature review and selection of articles for inclusion. All authors participated in drafting and/or critically revising the article for important intellectual content and have approved the submitted version.

Funding

Funding sources made no contribution to study design, collection, analysis or interpretation of data, writing of the report, or the decision to submit the article for publication.

Acknowledgements

Sources of Support: MH P50 MH090964 “Conte Center: Neurobiological and Developmental Antecedents to Suicidal Behavior” (Mann and Oquendo); R01 MH101107, R01 MH083704 (Tyrka); American Foundation for Suicide Prevention (Sublette); The Association for Research and Development of the School of Medicine, University of Lisbon (Gananca)

References (123)

  • E. Dieperink et al.

    Suicidal ideation during interferon-alpha2b and ribavirin treatment of patients with chronic hepatitis C

    Gen. Hosp. Psychiatry

    (2004)
  • D. Ducasse et al.

    A meta-analysis of cytokines in suicidal behavior

    Brain Behav. Immun.

    (2015)
  • C.P. Fagundes et al.

    Stressful early life experiences and immune dysregulation across the lifespan

    Brain Behav. Immun.

    (2013)
  • M.G. Frank et al.

    Microglia serve as a neuroimmune substrate for stress-induced potentiation of CNS pro-inflammatory cytokine responses

    Brain Behav. Immun.

    (2007)
  • M.G. Frank et al.

    Stress-induced glucocorticoids as a neuroendocrine alarm signal of danger

    Brain Behav. Immun.

    (2013)
  • C. Grudet et al.

    Suicidal patients are deficient in vitamin D, associated with a pro-inflammatory status in the blood

    Psychoneuroendocrinology

    (2014)
  • K. Hawton et al.

    Risk factors for suicide in individuals with depression: a systematic review

    J. Affect. Disord.

    (2013)
  • M. Huan et al.

    Suicide attempt and n-3 fatty acid levels in red blood cells: a case control study in China

    Biol. Psychiatry

    (2004)
  • S. Janelidze et al.

    Cytokine levels in the blood may distinguish suicide attempters from depressed patients

    Brain Behav. Immun.

    (2011)
  • S.B. Juengst et al.

    Exploratory associations with tumor necrosis factor-alpha, disinhibition and suicidal endorsement after traumatic brain injury

    Brain Behav. Immun.

    (2014)
  • D. Karlović et al.

    Serum concentrations of CRP, IL-6, TNF-α and cortisol in major depressive disorder with melancholic or atypical features

    Psychiatry Res.

    (2012)
  • P.A. Keedwell et al.

    The neural correlates of anhedonia in major depressive disorder

    Biol. Psychiatry

    (2005)
  • J.K. Kiecolt-Glaser et al.

    Omega-3 supplementation lowers inflammation and anxiety in medical students: a randomized controlled trial

    Brain Behav. Immun.

    (2011)
  • Y.K. Kim et al.

    TNF-alpha -308G>A polymorphism is associated with suicide attempts in major depressive disorder

    J. Affect. Disord.

    (2013)
  • Y.K. Kim et al.

    Differences in cytokines between non-suicidal patients and suicidal patients in major depression

    Prog. Neuropsychopharmacol. Biol. Psychiatry

    (2008)
  • G. Klinitzke et al.

    Obesity and suicide risk in adults–a systematic review

    J. Affect. Disord.

    (2013)
  • S. Lanquillon et al.

    Cytokine production and treatment response in major depressive disorder

    Neuropsychopharmacology

    (2000)
  • H.Y. Lee et al.

    Transforming growth factor-beta1 and major depressive disorder with and without attempted suicide: preliminary study

    Psychiatry Res.

    (2010)
  • Z. Li et al.

    Venlafaxine inhibits the upregulation of plasma tumor necrosis factor-alpha (TNF-α) in the Chinese patients with major depressive disorder: a prospective longitudinal study

    Psychoneuroendocrinology

    (2013)
  • D. Lindqvist et al.

    Interleukin-6 is elevated in the cerebrospinal fluid of suicide attempters and related to symptom severity

    Biol. Psychiatry

    (2009)
  • Y. Liu et al.

    Interleukin (IL)-6, tumour necrosis factor alpha (TNF-α) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: a meta-analysis and meta-regression

    J. Affect. Disord.

    (2012)
  • F.E. Lotrich et al.

    Risk for depression during interferon-alpha treatment is affected by the serotonin transporter polymorphism

    Biol. Psychiatry

    (2009)
  • M. Maes et al.

    Relationships between lower plasma l-tryptophan levels and immune-inflammatory variables in depression

    Psychiatry Res.

    (1993)
  • J.J. Mann et al.

    Candidate endophenotypes for genetic studies of suicidal behavior

    Biol. Psychiatry

    (2009)
  • A.M. May et al.

    Predicting future suicide attempts among depressed suicide ideators: a 10-year longitudinal study

    J. Psychiatr. Res.

    (2012)
  • B.S. McEwen

    Central effects of stress hormones in health and disease: understanding the protective and damaging effects of stress and stress mediators

    Eur. J. Pharmacol.

    (2008)
  • S. Mendlovic et al.

    Immune activation in non-treated suicidal major depression

    Immunol. Lett.

    (1999)
  • O. Morikawa et al.

    Effects of interferon-alpha, interferon-gamma and cAMP on the transcriptional regulation of the serotonin transporter

    Eur. J. Pharmacol.

    (1998)
  • M.F. O'Connor et al.

    To assess, to control, to exclude: effects of biobehavioral factors on circulating inflammatory markers

    Brain Behav. Immun.

    (2009)
  • E. Oliver et al.

    Docosahexaenoic acid attenuates macrophage-induced inflammation and improves insulin sensitivity in adipocytes-specific differential effects between LC n-3 PUFA

    J. Nutr. Biochem.

    (2012)
  • G.N. Pandey et al.

    Toll-like receptors in the depressed and suicide brain

    J. Psychiatr. Res.

    (2014)
  • G.N. Pandey et al.

    Proinflammatory cytokines in the prefrontal cortex of teenage suicide victims

    J. Psychiatr. Res.

    (2012)
  • A. Pierucci-Lagha et al.

    A functional serotonin transporter gene polymorphism and depressive effects associated with interferon-alpha treatment

    Psychosomatics

    (2010)
  • A.L. Beautrais et al.

    Prevalence and comorbidity of mental disorders in persons making serious suicide attempts: a case-control study

    Am. J. Psychiatry

    (1996)
  • J. Boehm et al.

    Putative role of TNF-alpha, interleukin-8 and ICAM-1 as indicators of an early inflammatory reaction after burn: a morphological and immunohistochemical study of lung tissue of fire victims

    J. Clin. Pathol.

    (2010)
  • B.S. Brodsky et al.

    The relationship of childhood abuse to impulsivity and suicidal behavior in adults with major depression

    Am. J. Psychiatry

    (2001)
  • F. Calabrese et al.

    Brain-derived neurotrophic factor: a bridge between inflammation and neuroplasticity

    Front. Cell. Neurosci.

    (2014)
  • L. Capuron et al.

    Basal ganglia hypermetabolism and symptoms of fatigue during interferon-alpha therapy

    Neuropsychopharmacology

    (2007)
  • D.D. Chaplin

    Overview of the immune response

    J. Allergy Clin. Immunol.

    (2010)
  • N. DiazGranados et al.

    Rapid resolution of suicidal ideation after a single infusion of an N-methyl-D-aspartate antagonist in patients with treatment-resistant major depressive disorder

    J. Clin. Psychiatry

    (2010)
  • Cited by (0)

    View full text